Literature DB >> 6424234

Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids.

K Nishikura, A ar-Rushdi, J Erikson, E DeJesus, D Dugan, C M Croce.   

Abstract

The productively rearranged immunoglobulin mu chain gene and the translocated cellular oncogene c-myc are transcribed at high levels both in human Burkitt lymphoma cells carrying the t(8;14) chromosome translocation and in mouse plasmacytoma X Burkitt lymphoma cell hybrids. In the experiments reported here these genes were found to be repressed in mouse 3T3 fibroblast X Burkitt lymphoma cell hybrids. Such repression probably occurs at the transcriptional level since no human mu- and c-myc messenger RNA's are detectable in hybrid clones carrying the corresponding genes. It is therefore concluded that the ability to express these genes requires a differential B cell environment. The results suggest that the 3T3 cell assay may not be suitable to detect oncogenes directly involved in human B cell oncogenesis, since 3T3 cells apparently are incapable of transcribing an oncogene that is highly active in malignant B cells with specific chromosomal translocations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424234     DOI: 10.1126/science.6424234

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

1.  Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

Authors:  S Fukushige; K Matsubara; M Yoshida; M Sasaki; T Suzuki; K Semba; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

2.  Extinction of expression of immunoglobulin genes in myeloma X fibroblast somatic cell hybrids.

Authors:  A Greenberg; R Ber; Z Kra-Oz; R Laskov
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter.

Authors:  E Kakkis; M Mercola; K Calame
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

4.  An active chromatin structure acquired by translocated c-myc genes.

Authors:  E Kakkis; J Prehn; K Calame
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

Review 5.  Genetics of B-cell neoplasia.

Authors:  C M Croce
Journal:  Eur J Epidemiol       Date:  1985-03       Impact factor: 8.082

6.  Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region.

Authors:  L C Showe; M Ballantine; K Nishikura; J Erikson; H Kaji; C M Croce
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

Review 7.  Oncogenes and their role in human neoplasia.

Authors:  D N Singh
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

8.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

Authors:  K Nishikura; S Goldflam; G A Vuocolo
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

9.  Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.

Authors:  Y Tsujimoto; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

10.  DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene.

Authors:  Y Tsujimoto; M M Bashir; I Givol; J Cossman; E Jaffe; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.